Moreover, Ghrelin and Ghrelin agonists have been highlighted as potential approaches to inhibit inflammation, gastrointestinal motility and sensitivity in the gastrointestinal tract, which could attenuate the occurrence of multiple organ failure induced by sepsis (25). This evidence concerns the gene GHRL and Multiple Organ Failure.